Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs LENZ Therapeutics, Inc. (LENZ)

Inovio Pharmaceuticals, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and LENZ Therapeutics, Inc. are of similar size ($112.2M and $107.5M). Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −586.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Inovio Pharmaceuticals, Inc. leads on 8 and LENZ Therapeutics, Inc. on 6.

Valuation

Metric INO LENZ Biotechnology median
P/E n/m n/m 8.50
P/S 209.44 4.78 9.71
P/B 18.49 0.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.85 0.64
EV/Sales 157.45 (5.36) 9.21
Earnings yield (91.92%) (125.08%) (33.15%)
Free cash flow yield (99.09%) (111.53%) (25.50%)

Profitability

Metric INO LENZ Biotechnology median
Gross margin 100.00% 93.69% 65.16%
Operating margin 0.00% (631.70%) 0.00%
Net margin 0.00% (586.74%) 0.00%
Free cash flow margin 0.00% (532.80%) 0.00%
Return on equity (409.87%) (59.21%) (56.36%)
Return on assets (114.64%) (55.52%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO LENZ Biotechnology median
Revenue growth (TTM) (54.82%) — 6.02%
EPS growth (last fiscal year) 54.18% (21.79%) 30.26%
Revenue growth, 5-year CAGR (61.18%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO LENZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 13.55 4.72
Net debt to EBITDA 0.70 3.22 0.96

Dividend

Metric INO LENZ Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric INO LENZ Biotechnology median
Market cap 107.53m 112.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack